Fecal Calprotectin: A Predictive Biomarker for Gastrointestinal Graft-versus-Host-Disease and a Prognostic Indicator in their Steroid therapy
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a promising therapeutic approach with risk of Acute Graft-versus-Host-Disease (aGvHD). aGvHD can affect the gastrointestinal tract, which results in gastrointestinal-GvHD (GI-GvHD). We assessed fecal calprotectin (FC) to determine if it can be applied as a GI-GvHD diagnostic marker and the response to steroid therapy.
Authors
- Shayan Zamani (ORCID: https://orcid.org/0009-0007-1204-195X)
- Mozhdeh Mohammadian (ORCID: https://orcid.org/0000-0003-4957-8797)
- Sedigheh Sadat Akhlaghi (ORCID: https://orcid.org/0000-0002-8365-3175)
- Mohammad Reza Moshari
- Elham Roshandel (ORCID: https://orcid.org/0000-0002-3698-4342)
- Mahmoud Dehghani Ghorbi (ORCID: https://orcid.org/0000-0001-7272-3804)
- Sayeh Parkhideh (ORCID: https://orcid.org/0000-0002-5200-8915)
Institutions
- Tarbiat Modares University (IR)
- Imam Hossein Hospital (IR)
- Shahid Beheshti University (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Annals of Cancer Research and Therapy
- Published
- 2024-10-16
- DOI
- https://doi.org/10.4993/acrt.32.39
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00